BMJ Open (May 2022)

Rationale and design of a multicentre, 12-week, randomised, double-blind, placebo-controlled, parallel-group, investigator-initiated trial to investigate the efficacy and safety of elobixibat for chronic constipation

  • Takuma Higurashi,
  • Jun Arimoto,
  • Atsushi Nakajima,
  • Keisuke Ariyoshi,
  • Shunsuke Oyamada,
  • Masataka Taguri,
  • Masato Yoneda,
  • Takaomi Kessoku,
  • Takashi Kobayashi,
  • Anna Ozaki,
  • Tomoyuki Iwasaki,
  • Takeo Kurihashi,
  • Michihiro Iwaki,
  • Kunihiro Hosono,
  • Eiji Sakai,
  • Kosuke Tanaka,
  • Atsushi Yamamoto,
  • Kota Takahashi,
  • Yuki Kasai,
  • Tsutomu Yoshihara,
  • Noboru Misawa,
  • Takayuki Kato,
  • Akiko Fuyuki,
  • Hideyuki Chiba,
  • Machiko Nakatogawa,
  • Ayao Suzuki,
  • Noritoshi Kobayashi,
  • Yasushi Ichikawa

DOI
https://doi.org/10.1136/bmjopen-2021-060704
Journal volume & issue
Vol. 12, no. 5

Abstract

Read online

No abstracts available.